Here are Lucas’s comments regarding the options.
OptiCept has reached an agreement to bring forward the exercise period for all outstanding warrants, resulting in the subscription of 4,350,000 shares worth around 13 MSEK. We had previously flagged that this was a possibility, so the outcome is roughly in line with our expectations, even though the exercise of the warrants was in our estimates for 2025. This will therefore have a minor impact on our estimates.